Literature DB >> 32266536

Unilateral versus bilateral lymph-nodal metastases and oncologic outcome in vulvar cancer patients.

Andrea Papadia1,2, Lisa Ehm1, Maria Luisa Gasparri3,4, Junjie Wang1,5, Anda Petronela Radan1, Michael D Mueller1.   

Abstract

PURPOSE: To evaluate the difference in oncologic outcome between vulvar cancer patients with uni- and bilateral inguino-femoral lymph nodal involvement and to identify factors affecting their oncologic outcome
MATERIALS AND METHODS: Patients who underwent inguino-femoral lymphadenectomy for vulvar cancer were classified into three groups according to their lymph nodal status at the histology analysis (negative, positive one side, positive bilaterally). PFS and OS survival were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed to analyze factors predicting overall survival and progression-free survival. Multivariable models were used for variables reporting a p value ≤ 0.1 at the univariate analysis. p values ≤ 0.05 were considered statistically significant.
RESULTS: One hundred and forty-six patients were considered for the analysis. Patients with bilaterally negative lymph nodes had significantly longer PFS and OS as compared to patients with unilateral and bilateral involvement. Patients with unilateral lymph nodal involvement had better PFS than patients with bilateral lymph nodal involvement. Among these patients, the difference in the OS approached but did not reach statistical significance. At the multivariate analysis, the tumor size affected PFS and lymph nodal involvement affected OS.
CONCLUSION: Vulvar cancer patients with bilateral positive lymph nodes have worse oncologic outcome as compared to patients with unilateral lymph nodal involvement; similarly, patients with unilateral lymph nodal involvement have worse oncological outcome as compared to patients with bilateral negative lymph nodes. Furthermore, tumor size and lymph nodal status are independent factors predicting recurrence rate and overall survival, respectively.

Entities:  

Keywords:  Lymph node metastases; Overall survival; Progression-free survival; Vulvar cancer

Mesh:

Year:  2020        PMID: 32266536     DOI: 10.1007/s00432-020-03196-9

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  1 in total

1.  Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.

Authors:  Sven Mahner; Julia Jueckstock; Felix Hilpert; Petra Neuser; Philipp Harter; Nikolaus de Gregorio; Annette Hasenburg; Jalid Sehouli; Annika Habermann; Peter Hillemanns; Sophie Fuerst; Hans-Georg Strauss; Klaus Baumann; Falk Thiel; Alexander Mustea; Werner Meier; Andreas du Bois; Lis-Femke Griebel; Linn Woelber
Journal:  J Natl Cancer Inst       Date:  2015-01-24       Impact factor: 13.506

  1 in total
  3 in total

1.  Safety and Benefit Of Sentinel Lymph Nodes Biopsy Compared to Regional Lymph Node Dissection in Primary Vulvar Cancer Patients Without Distant Metastasis and Adjacent Organ Invasion: A Retrospective Population Study.

Authors:  Weili Zhou; Yang Bai; Yangyang Yue
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

2.  Developing and Validating Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of Patients With Primary Vulvar Squamous Cell Cancer.

Authors:  Weili Zhou; Yangyang Yue
Journal:  Front Med (Lausanne)       Date:  2021-12-03

3.  Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study.

Authors:  Linn Woelber; Mareike Bommert; Philipp Harter; Katharina Prieske; Christine Zu Eulenburg; Julia Jueckstock; Felix Hilpert; Nikolaus de Gregorio; Severine Iborra; Jalid Sehouli; Atanas Ignatov; Peter Hillemanns; Sophie Fuerst; Hans-Georg Strauss; Klaus Baumann; Matthias Beckmann; Alexander Mustea; Werner Meier; Sven Mahner; Anna Jaeger
Journal:  Ann Surg Oncol       Date:  2021-03-15       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.